Will you be at the J.P. Morgan Healthcare Conference in January? If so, I hope you’ll join us for the FierceBiotech Executive Breakfast, Get Good Science and the Money will Follow [5] on January 9th at the Fairmont Hotel in San Francisco. The event will run from 7:00AM-8:30AM and will include a full buffet breakfast.
Biotech IPOs struggled until the second quarter of 2017, but investments through early raises in young biotechs reached major levels – with around half of 2016 Fierce15 winners seeing a $50M series A or B round in 2016 or 2017. Are we seeing a genuine reblooming of biomedical innovation, and is biotech, notably young biotech, ready to bring in the money, partners and investors needed to fuel R&D?
We have a great lineup of speakers including:
- Jeremy M. Levin, D.Phil., MB BChir, Chairman of the Board of Directors and CEO, Ovid Therapeutics
- Alexis Borisy, Partner, Third Rock Ventures
- Andrew Allen, M.D., Ph.D., Co-founder, President and CEO, Gritstone Oncology
- Stephen Ubl, President and Chief Executive Officer, PhRMA
- Bernie Zeiher, President of Development, Astellas
Seats are limited so don’t delay. Click here [5] to reserve your seat today.